DK2983652T3 - Behandling af autismespektrumforstyrrelse - Google Patents
Behandling af autismespektrumforstyrrelse Download PDFInfo
- Publication number
- DK2983652T3 DK2983652T3 DK14724593.0T DK14724593T DK2983652T3 DK 2983652 T3 DK2983652 T3 DK 2983652T3 DK 14724593 T DK14724593 T DK 14724593T DK 2983652 T3 DK2983652 T3 DK 2983652T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- autism spectrum
- spectrum disorder
- disorder
- autism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/860,824 US9211284B2 (en) | 2013-04-11 | 2013-04-11 | Diagnosis and treatment of P.R.I.C.E. syndrome |
| US14/166,483 US20140309270A1 (en) | 2013-04-11 | 2014-01-28 | Diagnosis and treatment of a form of autistic spectrum disorder |
| PCT/US2014/032933 WO2014168820A1 (en) | 2013-04-11 | 2014-04-04 | Treatment of autistic spectrum disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2983652T3 true DK2983652T3 (da) | 2021-01-11 |
Family
ID=50732308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14724593.0T DK2983652T3 (da) | 2013-04-11 | 2014-04-04 | Behandling af autismespektrumforstyrrelse |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20140309270A1 (da) |
| EP (1) | EP2983652B1 (da) |
| CA (2) | CA2909302C (da) |
| DK (1) | DK2983652T3 (da) |
| ES (1) | ES2837829T3 (da) |
| IL (1) | IL242013B (da) |
| WO (1) | WO2014168820A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108351862B (zh) * | 2015-08-11 | 2023-08-22 | 科格诺亚公司 | 利用人工智能和用户输入来确定发育进展的方法和装置 |
| GB2549278B (en) | 2016-04-11 | 2021-02-17 | Gw Res Ltd | Use of cannabidivarin in the treatment of autism spectrum disorder |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3236857A (en) | 1961-10-09 | 1966-02-22 | Boehringer Sohn Ingelheim | 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products |
| US5484607A (en) | 1993-10-13 | 1996-01-16 | Horacek; H. Joseph | Extended release clonidine formulation |
| US5854290A (en) | 1995-09-21 | 1998-12-29 | Amy F. T. Arnsten | Use of guanfacine in the treatment of behavioral disorders |
| US6287599B1 (en) | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| US6811794B2 (en) | 2001-12-20 | 2004-11-02 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| CA2645855C (en) | 2006-03-16 | 2015-02-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| WO2009052073A2 (en) | 2007-10-18 | 2009-04-23 | Allergan, Inc. | Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists |
| PL2215047T3 (pl) | 2007-11-02 | 2014-05-30 | Emisphere Tech Inc | Sposób leczenia niedoborów witaminy b12 |
| US8287903B2 (en) | 2011-02-15 | 2012-10-16 | Tris Pharma Inc | Orally effective methylphenidate extended release powder and aqueous suspension product |
-
2014
- 2014-01-28 US US14/166,483 patent/US20140309270A1/en not_active Abandoned
- 2014-04-04 WO PCT/US2014/032933 patent/WO2014168820A1/en active Application Filing
- 2014-04-04 EP EP14724593.0A patent/EP2983652B1/en active Active
- 2014-04-04 CA CA2909302A patent/CA2909302C/en active Active
- 2014-04-04 CA CA3138610A patent/CA3138610C/en active Active
- 2014-04-04 ES ES14724593T patent/ES2837829T3/es active Active
- 2014-04-04 DK DK14724593.0T patent/DK2983652T3/da active
-
2015
- 2015-10-11 IL IL242013A patent/IL242013B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA3138610C (en) | 2024-02-13 |
| US20140309270A1 (en) | 2014-10-16 |
| CA2909302A1 (en) | 2014-10-16 |
| WO2014168820A1 (en) | 2014-10-16 |
| CA3138610A1 (en) | 2014-10-16 |
| ES2837829T3 (es) | 2021-07-01 |
| CA2909302C (en) | 2021-12-21 |
| EP2983652B1 (en) | 2020-10-21 |
| EP2983652A1 (en) | 2016-02-17 |
| IL242013B (en) | 2019-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2968208T3 (da) | Behandling af kataplexi | |
| DK2983787T3 (da) | Fremgangsmåde til behandling af posttraumatisk stresssygdom | |
| DK3134530T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3035926T3 (da) | Forbindelser og fremgangsmåder til behandling af en epilepsilidelse | |
| DK3043816T3 (da) | Anti-b7-h1-antistoffer til behandling af tumorer | |
| DK3076967T3 (da) | Fremgangsmåder til behandling af residuelle symptomer på skizofreni | |
| DK3033086T3 (da) | Kombinationsterapi til behandling af cancer | |
| DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK3087183T3 (da) | Modulation af angiopoietin-3-lignende ekspression | |
| DK3076976T3 (da) | Fremgangsmåder til behandling af cancer | |
| BR112015019232A2 (pt) | filtração | |
| DK2964315T3 (da) | System til behandling af neuromotorisk dysfunktion | |
| DK2961388T3 (da) | Kombinationer af lægemidler | |
| DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
| DK3021838T3 (da) | Behandling af fedme | |
| DK3626270T3 (da) | Behandling af kardiovaskulære sygdomme | |
| DK3068854T3 (da) | Fjernelse af uønskede propanolkomponenter | |
| DK2976359T4 (da) | Fremgangsmåder til behandling af osteogenesis imperfecta | |
| DK3060226T3 (da) | Fagterapi af pseudomonasinfektioner | |
| DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom | |
| DK3052102T3 (da) | Sammensætninger til behandling af cancere | |
| DK3063264T3 (da) | Tørring af mikroorganismer | |
| BR112016010457A2 (pt) | Modificação de poliamidas | |
| DK3016682T3 (da) | Metoder til behandling af kræft | |
| DK2822301T3 (da) | Bestemmelse af individuelle HRTF |